PTM can mediate NAFLD development by affecting oxidative stress, lactate accumulation, autophagy, insulin resistance, and inflammation, and the major signaling pathways affected include PPAR, AMPK, AKT, and JAK2–STAT3. Here, STAT3 is linked to metabolic dysfunction-associated steatotic liver disease.